Lotus Clinical Research vs YPrime

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/lotuscr/yprime

Category	Lotus Clinical Research	YPrime
Listed site	cro	cro
Summary	Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.	YPrime delivers configurable eCOA, IRT, and eConsent clinical trial technology platforms with consulting services, supporting ~1,000 studies globally across 19+ therapeutic areas.
Services	Clinical Operations Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Data Management & eClinical Biostatistics & Statistical Programming Medical Writing US FDA Regulatory Strategy Regulatory Affairs Clinical Trial Services CNS Specialty Services Cardiovascular & Metabolic Specialty Services Immunology & Inflammation Services Clinical Imaging Core Lab	Data Management & eClinical Biostatistics & Statistical Programming Clinical Operations Clinical Trial Services Medical Writing Regulatory Affairs Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing
Modalities	Data not yet provided.	Data not yet provided.
Indications	Oncology Neurology Psychiatry Metabolic	Oncology Immunology Neurology Metabolic Infectious Disease Rare Disease Ophthalmology
Locations	Headquarters, Edison, NJ, United States Headquarters, United States Research Sites Network, United States, US	Data not yet provided.
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.